ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification.
about
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromesThe assessment of Ki-67 as a prognostic marker in neuroendocrine tumours: a systematic review and meta-analysis.Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative ApproachComparison of relapse-free survival in gastric neuroendocrine carcinoma (WHO grade 3) and gastric carcinoma.A single institution's 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram.Diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors: current data on a prospectively collected, retrospectively analyzed clinical multicenter investigation.Observational study of patients with gastroenteropancreatic and bronchial neuroendocrine tumors in Argentina: Results from the large database of a multidisciplinary group clinical multicenter study.Neuroendocrine tumors of the gastrointestinal tract: Case reports and literature review.ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors.ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.High-grade KIT-negative sarcoma of the small bowel in a patient with chronic myeloid leukemia receiving long-term tyrosine kinase inhibitors.Therapy for metastatic pancreatic neuroendocrine tumors.Relationship between clinical characteristics and survival of gastroenteropancreatic neuroendocrine neoplasms: A single-institution analysis (1995-2012) in South China.Correlation of monoclonal and polyclonal somatostatin receptor 5 antibodies in pancreatic neuroendocrine tumors.Multimodal management of neuroendocrine liver metastases.NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreasCopy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridizationIdentification of candidate serum proteins for classifying well-differentiated small intestinal neuroendocrine tumorsNew model for gastroenteropancreatic large-cell neuroendocrine carcinoma: establishment of two clinically relevant cell lines.Management of early gastrointestinal neuroendocrine neoplasms.Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)Clinicopathological features and survival analysis of gastroenteropancreatic neuroendocrine neoplasms: a retrospective study in a single center of ChinaSmall pancreatic and periampullary neuroendocrine tumors: resect or enucleate?Chromogranin A as a marker for diagnosis, treatment, and survival in patients with gastroenteropancreatic neuroendocrine neoplasm.Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study.Gene Expression of Glucose Transporter 1 (GLUT1), Hexokinase 1 and Hexokinase 2 in Gastroenteropancreatic Neuroendocrine Tumors: Correlation with F-18-fluorodeoxyglucose Positron Emission Tomography and Cellular Proliferation.Compound gastroenteropancreatic neuroendocrine and gastrointestinal stromal tumors in the stomach: A case report.Clinical validation of the gastrointestinal NET grading system: Ki67 index criteria of the WHO 2010 classification is appropriate to predict metastasis or recurrence.Proposal for a standardized pathology report of gastroenteropancreatic neuroendocrine tumors: prognostic significance of pathological parametersDiffering Clinical Courses and Prognoses in Patients With Gastric Neuroendocrine Tumors Based on the 2010-WHO Classification Scheme.Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advancesRecurrence of a carcinoid tumor of the ovary 13 years after the primary surgery: A case reportA novel predictive model based on preoperative blood neutrophil-to-lymphocyte ratio for survival prognosis in patients with gastric neuroendocrine neoplasms.Comparison of the prognostic values of the 2010 WHO classification, AJCC 7th edition, and ENETS classification of gastric neuroendocrine tumors.Update on the management of gastroenteropancreatic neuroendocrine tumors with emphasis on the role of imaging.Gastroenteropancreatic neuroendocrine tumors: recommendations of Turkish multidisciplinary neuroendocrine tumor study group on diagnosis, treatment and follow-up.Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE).Preclinical assesement of survivin and XIAP as prognostic biomarkers and therapeutic targets in gastroenteropancreatic neuroendocrine neoplasia.The pathological diagnosis of neuroendocrine tumors: common questions and tentative answers.Immunohistochemical expression and prognostic value of ER, PR and HER2/neu in pancreatic and small intestinal neuroendocrine tumors.
P2860
Q24603675-62B18954-669A-4D10-8742-00F742E98787Q30252003-0FC0D51A-EE89-43B2-B5AB-D01B4CA7E00AQ30491728-2F4A6021-54ED-4BF3-81DB-318D5FA8D7EAQ33632569-40AB170B-5179-4951-BC8B-0927ED086537Q33720743-9862F0CA-83BB-4F58-8165-9E436B59553BQ33863393-9AB3A003-CAAD-49D8-BF01-E1166D748B78Q33932715-2CACA62C-1ACE-47AD-9EA5-D24EE718F5B5Q34049125-1A485A21-A073-47E0-ABFC-186A17F6B15DQ34248466-C3C08006-EBC6-477B-B13C-E48AB5C6F01BQ34248487-1B190F8C-4244-4366-98DA-AAB91D056152Q34283282-1A8C980B-A57C-4F85-A12A-E492B734C8AFQ34357869-DC36EFBA-A90F-4C1B-A484-A070637A7CCDQ34495609-DFB988DC-88B0-4D2C-895D-7C94E212CA0AQ34511149-0186DFB8-EE17-49E2-8F3F-DB8DEB568E7EQ34528199-11AB442D-9A9F-4433-BDD2-A63DBBFA0136Q35001777-3B152354-BEDE-405C-B299-B8FD31C9A9C7Q35027292-118BBB13-41AF-477D-966F-A0490ECF8171Q35055381-77B55D88-0B61-4921-8FCE-D1F9171A6B11Q35097493-8E79CCB7-6793-4D2A-AAFE-6B6F4CDCEC5DQ35174840-BB757A38-9030-412F-8DAF-7EAE434FEA72Q35760798-AE0C16C6-672A-45AA-9D06-A2D8862F5BB0Q35812801-25BB6FC3-E1C1-476B-B64A-326DC4FA4080Q35967362-30323ED5-D7C8-4FEC-B5FD-BA5986D890DFQ36152602-CF40D336-089A-4B19-B9B8-9AA53DC68660Q36306654-E0C3357A-A1F6-4012-86A0-9012DE34CAEEQ36335121-0EC26080-D669-4242-A0A9-E788D1499874Q36336101-C3686177-E90D-4385-935F-86D83B6920E8Q36831573-44C59EF4-F315-42A6-830E-4797BD6CF077Q36983412-1BB19136-1C3E-46BB-AB81-DCB6EA39DE28Q37026099-83C4CCAF-A6D7-4C1F-90EB-0C6452383E19Q37125550-9C48A26B-3B8E-4F5D-AB50-13FA7C7A0388Q37269457-2FC03054-90F9-4909-AC07-6C028C50E392Q37520436-CE813867-4520-4DD4-A2FC-55D15EEDF08DQ37605547-A4CC3899-1C7D-48C8-9830-6AD5CB0BE9A4Q37673407-47676FFE-8A35-41F8-8F89-DD54162C9DFAQ37675588-D0EDA6A1-80DF-4EB5-84CA-F8AFF1811EF5Q37688704-5A97466D-D384-4F52-BB3E-FDC6E241FAF2Q37702716-B0377741-BE4F-4D0E-83A0-8FCF363C1708Q37846130-D59AA122-E934-4E57-B7E1-E0B1179BC2C3Q37864496-247FD863-684A-4141-9C8B-0A9812959134
P2860
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
ENETS Consensus Guidelines for ...... eir prognostic stratification.
@en
ENETS Consensus Guidelines for ...... eir prognostic stratification.
@nl
type
label
ENETS Consensus Guidelines for ...... eir prognostic stratification.
@en
ENETS Consensus Guidelines for ...... eir prognostic stratification.
@nl
prefLabel
ENETS Consensus Guidelines for ...... eir prognostic stratification.
@en
ENETS Consensus Guidelines for ...... eir prognostic stratification.
@nl
P2093
P50
P356
P1433
P1476
ENETS Consensus Guidelines for ...... eir prognostic stratification.
@en
P2093
Anne Couvelard
Anne-Marie McNicol
European Neuroendocrine Tumor Society
Mallorca Consensus Conference participants
Mauro Papotti
Ola Nilsson
Paul Komminoth
Ursula Plöckinger
P304
P356
10.1159/000182196
P50
P577
2009-08-28T00:00:00Z